References
- MARTIN P, BENIGER RJ, HAMON M, FUECH AJ: Antidepressant-like action of 8-0H-DPAT, a 5-HT1k agonist, in the learned helplessness paradigm: evidence for postsynaptic mechanism. Behav. Brain Res. (1990) 38:135–144.
- WIELAND S, LUCKI I: Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test. Psychopharmacology (1990) 101:497–504.
- MELIN C, VALLGARDA J, NELSON DL et al.: A 3-D model for 5-HT1A receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-Hydroxy-2-(dipropylamino)tetralin. J. Med. Chem (1991) 34:497–510.
- KING KA, HOLTNIAN JR: Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx. J. PharmacoL Exp. Ther. (1990) 252:665–674.
- FOZARD JR, KILBINGER H: 8-0H-DPAT inhibits transmitter release from guinea-pig enteric cholinergic neurones by activating 5-HT1A receptors. Br. J. PharmacoL (1985) 86:601P.
- WOUTERS W, TULP MTM, BREVAN P: Flesinoxan lowers blood pressure and heart rate in cats via 5-HTIA receptors. Eur. .1. Pharmacol. (1988) 149:213–223.
- HIBERT M, MOSER P: MDL 72832 and MDL 73005EF: Novel, potent and selective 5-HT1A receptor ligands with different pharmacological properties. Drugs Fut. (1990) 15:159–70.
- ROBERTSON DW, FULLER RW: Progress in antidepressant drugs. Annual Rep. Med. Chem. (1991) 26:23–32.
- JUNGE B, RICHTER B, GLASER T et aL, EP–272534–A.